All blog items

The National Organization for Rare Disorders (NORD) has designated the Duke Health Rare Disease Center as a NORD Rare Disease Center of Excellence, joining a highly select group of 31 medical centers, nationwide, as part of an innovative network seeking to expand access and advance care and research for rare disease patients in the United States.

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

Jacqueline Barnett, program director for the Duke Physician Assistant Program, is the Blue Devil of the Week!

In a virtual media briefing with reporters, Dr. Emmanuel Walter Jr., discussed his study findings, the overall vaccine trial process, potential side effects, and the need for herd immunity in American communities.

The awards from the Aligning Science Across Parkinson’s (ASAP) initiative position Duke as a national leader in understanding the origins and development of this devastating movement disorder.

A Q&A with Nobel Laureate Jennifer Doudna

The American Society of Human Genetics (ASHG) is a professional organization for researchers and clinicians who specialize in human genetics. They work to advance human genetics and genomics in science, healthy and society through research, education and advocacy. The ASHG Annual Meeting was held October 18-22, and several members of the Precision Genomics Collaboratory presented their research:

An unconventional National Hispanic Heritage Month panel held at Duke unpacked and thoroughly discussed many complexities found within the Latinx identity, particularly for those living in the U.S. South.

Election to NAM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

These particular grant awards will boost evidence-based research into the biological and societal drivers of breast cancer metastasis and mortality and will catalyze the development of potential new treatments.